Come up with a name for your new list and we'll add to it:
AmbioPharm raised a round of funding on November 20, 2014. Investors include
MVM Life Science Partners.
Ambio Holdings, dba AmbioPharm (APi), is a global peptide active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO). It has established a custom peptide supply …